Epipole is a small but rapidly expanding company growing from a startup to a fully fledged manufacturer.
We are developing a unique mass market monitoring and screening platform for diabetic retinopathy. The system is a low cost tool for use in tele-medicine applications. It is highly portable allowing it to be used in geographically remote areas and in populations that are traditionally hard to reach. The system will have very low manufacturing costs, achieved by innovative and elegant design.
Epipole are an ethically based company focused primarily on the Developing World where medical instruments are in short supply.